Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nysom, K.
Right arrow Articles by Molgaard, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nysom, K.
Right arrow Articles by Molgaard, C.

Journal of Clinical Oncology, Vol 16, 3752-3760, Copyright © 1998 by American Society of Clinical Oncology


ARTICLES

Bone mass after treatment for acute lymphoblastic leukemia in childhood

K Nysom, K Holm, KF Michaelsen, H Hertz, J Muller and C Molgaard
Section of Paediatric Haematology, The Juliane Marie Centre, Rigshospitalet, Copenhagen, Denmark. nysom@dadlnet.dk

PURPOSE: To study bone mass after childhood acute lymphoblastic leukemia (ALL) and determine if reduced bone mass is related to previous therapy or endocrine status at follow-up. PATIENTS AND METHODS: We studied 95 survivors of childhood ALL who were in first remission a median of 11 years (range, 3 to 23 years) after diagnosis and who had never been irradiated outside a cranial field. The bone mass was measured by dual-energy x-ray absorptiometry. The results were compared with data on 396 local controls. RESULTS: Adjusted for sex and age, the mean whole-body bone mineral content (BMC) and bone mineral areal density (BMDA) were both significantly reduced (0.4 SDs less than the predicted mean value). This was mainly caused by reduced bone mass in the 33 participants who were aged 19 years or older at follow-up. In these young adults, the mean height for age, bone area for height, and BMC for bone area were all significantly reduced. This indicated that the reduced whole-body bone mass was caused by both reduced bone size and reduced size-adjusted bone mass. Reduced bone size was related to previous cranial irradiation. Reduced size-adjusted bone mass was not significantly related to age at diagnosis or at follow-up, length of follow-up, cranial irradiation, cumulative dose of methotrexate or corticosteroids, or endocrine status at follow-up. CONCLUSION: The whole-body bone mass was reduced 11 years after diagnosis of childhood ALL. If these abnormalities remain, survivors of childhood ALL will have an increased risk for osteoporotic fractures later in life.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M Jarfelt, H Fors, B Lannering, and R Bjarnason
Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia
Eur. J. Endocrinol., February 1, 2006; 154(2): 303 - 309.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Marinovic, S. Dorgeret, B. Lescoeur, C. Alberti, M. Noel, P. Czernichow, G. Sebag, E. Vilmer, and J. Leger
Improvement in Bone Mineral Density and Body Composition in Survivors of Childhood Acute Lymphoblastic Leukemia: A 1-Year Prospective Study
Pediatrics, July 1, 2005; 116(1): e102 - e108.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. D. Brennan, Z. Mughal, S. A. Roberts, K. Ward, S. M. Shalet, T. O. B. Eden, A. M. Will, R. F. Stevens, and J. E. Adams
Bone Mineral Density in Childhood Survivors of Acute Lymphoblastic Leukemia Treated without Cranial Irradiation
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
K. C. Oeffinger and M. M. Hudson
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
W H. B Wallace, A. Blacklay, C. Eiser, H. Davies, M. Hawkins, G. A Levitt, and M. E M Jenney
Regular review: Developing strategies for long term follow up of survivors of childhood cancer
BMJ, August 4, 2001; 323(7307): 271 - 274.
[Full Text] [PDF]


Home page
JCOHome page
K. Nysom, K. Holm, H. Hertz, J. Muller, K. F. Michaelsen, and C. Molgaard
Bone Mass After Treatment for Acute Lymphoblastic Leukemia in Childhood
J. Clin. Oncol., June 1, 2001; 19(11): 2970 - 2971.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
B. BRENNAN and S M SHALET
Reduced bone mineral density at completion of chemotherapy for a malignany
Arch. Dis. Child., October 1, 1999; 81(4): 372a - 372.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Arikoski, J. Komulainen, P. Riikonen, R. Voutilainen, M. Knip, and H. Kröger
Alterations in Bone Turnover and Impaired Development of Bone Mineral Density in Newly Diagnosed Children with Cancer: A 1-Year Prospective Study
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3174 - 3181.
[Abstract] [Full Text]


Home page
Journal of Pediatric Oncology NursingHome page
J. Harvey, W. L. Hobbie, S. Shaw, and S. Bottomley
Providing Quality Care in Childhood Cancer Survivorship: Learning From the Past, Looking to the Future
Journal of Pediatric Oncology Nursing, January 1, 1999; 16(3): 117 - 125.
[Abstract] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online